- 关于 Tocris
The first GMP small molecules for stem cell therapy are now available from Tocris.
The Tocris range of cGMP small molecules is manufactured following relevant sections of ICH Q7 guidelines. Our highly qualified team has full control over the cGMP process, meaning we can ensure: a quality-assured manufacturing system, batch-to-batch consistency, consistent supply, traceability from starting material to final product, and animal-free production. Partner with the market leader for stem cell compounds today, and let Tocris help you develop the next stem cell therapy.
Please complete the form below to let us know your GMP compound requirements.